In this study, we measured total and free VEGF, sVEGFR-1 and VEGFR-2, as well as Her-2/neu and thymidine phosphorylase (TP) levels in breast tumour cytosols quantitatively and then evaluated those prognostic values. The gene discussed is ERBB2; the disease is breast neoplasm.